Puma Biotech (PBYI) delivered earnings and revenue surprises of +36.36% and +4.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Gujarat's startup scene is experiencing a funding revival, attracting nearly ₹400 crore since April. RENÉE Cosmetics led with ...

Plus, the Duolingo CEO joined Figma’s board, a local biotech founder lands on Forbes’ list and more Pittsburgh power moves.

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story ...

German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion euros ($1.37 ...

Research Capital analyst Greg McLeish McLeish maintained his “Buy” rating and $3.00 target price on the stock.

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – Cancer is no longer just a disease of ...